Esketamine Combined with Dexmedetomidine to reduce Visceral Pain During elective Cesarean Section Under Combined Spinal-Epidural Anesthesia: A double-Blind Randomized Controlled Study

References

• Klimek M, Rossaint R, van de Velde M, Heesen M. Combined spinal-epidural vs. spinal anaesthesia for caesarean section: meta-analysis and trial-sequential analysis. Anaesthesia. 2018;73(7):875–888. doi:10.1111/anae.14210
   PubMed Web of Science ®Google Scholar
• Ng KW, Parsons J, Cyna AM, Middleton P. Spinal versus epidural anaesthesia for caesarean section. Cochrane Database Syst Rev. 2004;2012(4). doi:10.1002/14651858.CD003765.pub2
   Google Scholar
• Liu M, Wang B, Prudence B, Chen X. Effect of different doses of epidural dexmedetomidine on reducing visceral traction reaction for cesarean section: a double-blind randomized controlled trial. J Anes. 2023;37(3):371–378. doi:10.1007/s00540-023-03166-8
   PubMed Web of Science ®Google Scholar
• L-L X, Wang C, Deng C-M, et al. Efficacy and safety of esketamine for supplemental analgesia during elective cesarean delivery. JAMA Network Open. 2023;6(4). doi:10.1001/jamanetworkopen.2023.9321
   Web of Science ®Google Scholar
• Plaat F, Stanford SER, Lucas DN, et al. Prevention and management of intra‐operative pain during caesarean section under neuraxial anaesthesia: a technical and interpersonal approach. Anaesthesia. 2022;77(5):588–597. doi:10.1111/anae.15717
   PubMed Web of Science ®Google Scholar
• Patel R, Kua J, Sharawi N, et al. Inadequate neuraxial anaesthesia in patients undergoing elective caesarean section: a systematic review. Anaesthesia. 2022;77(5):598–604. doi:10.1111/anae.15657
   PubMed Web of Science ®Google Scholar
• Chen X-R, Gao T, Zhang Y, Peng M-Q. Addition of low-dose sufentanil to ropivacaine for reducing shivering and visceral traction pain during cesarean section. J Int Med Res. 2021;49(5). doi:10.1177/03000605211017000
   Web of Science ®Google Scholar
• Lu Q, Dong C-S, J-M Y, et al. The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus. Medicine. 2018;97(38):e12404. doi:10.1097/md.0000000000012404
   PubMed Web of Science ®Google Scholar
• Ishiyama T, Yamaguchi T, Kashimoto S, Kumazawa T. Effects of epidural fentanyl and intravenous flurbiprofen for visceral pain during cesarean section under spinal anesthesia. J Anes. 2001;15(2):69–73. doi:10.1007/s005400170029
   PubMedGoogle Scholar
• Smith LA, Burns E, Cuthbert A. Parenteral opioids for maternal pain management in labour. Cochrane Database Syst Rev. 2018;2018(6). doi:10.1002/14651858.CD007396.pub3
   Google Scholar
• Zhang X, Wang J, X-H A, et al. Optimum dose of spinal ropivacaine with or without single intravenous bolus of S-ketamine during elective cesarean delivery: a randomized, double-blind, sequential dose-finding study. BMC Pregnancy Childbirth. 2021;21(1). doi:10.1186/s12884-021-04229-y
   Web of Science ®Google Scholar
• McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383–399. doi:10.1176/appi.ajp.2020.20081251
   PubMed Web of Science ®Google Scholar
• Kaur U, Pathak BK, Singh A, Chakrabarti SS. Esketamine: a glimmer of hope in treatment-resistant depression. European Arch Psy Clini Neuro. 2019;271(3):417–429. doi:10.1007/s00406-019-01084-z
   PubMed Web of Science ®Google Scholar
• Shen J, Song C, Lu X, et al. The effect of low-dose esketamine on pain and post-partum depression after cesarean section: a prospective, randomized, double-blind clinical trial. Frontiers in Psychiatry. 2023:13. 10.3389/fpsyt.2022.1038379.
   Google Scholar
• Yang SQ, Zhou YY, Yang ST, et al. Effects of different doses of esketamine intervention on postpartum depressive symptoms in cesarean section women: a randomized, double-blind, controlled clinical study. J Affective Disorders. 2023;339:333–341. doi:10.1016/j.jad.2023.07.007
   PubMed Web of Science ®Google Scholar
• Lema GF, Gebremedhn EG, Gebregzi AH, Desta YT, Kassa AA. Efficacy of intravenous tramadol and low-dose ketamine in the prevention of post-spinal anesthesia shivering following cesarean section: a double-blinded, randomized control trial. Int J Women’s Health. 2017;Volume 9:681–688. doi:10.2147/ijwh.S139655
   Google Scholar
• Liang Z, Zhou T, Wang M, Li Y. Neonatal outcomes when intravenous esketamine is added to the parturients transferred from labor analgesia to emergency cesarean section: a retrospective analysis report. BMC Anesthesiology. 2023;23(1). doi:10.1186/s12871-023-02132-x
   Web of Science ®Google Scholar
• Riccardi A, Serra S, De Iaco F, Fabbri A, Shiffer D, Voza A. Uncovering the Benefits of the Ketamine–Dexmedetomidine Combination for Procedural Sedation during the Italian COVID-19 Pandemic. J Clin Med. 2023;12(9):3124. doi:10.3390/jcm12093124
   PubMed Web of Science ®Google Scholar
• Zhang Q, L-y X, Liang W-D, et al. Intrathecal dexmedetomidine combined with ropivacaine in cesarean section: a prospective randomized double-blind controlled study. Front Med. 2022:9. 10.3389/fmed.2022.922611.
   Web of Science ®Google Scholar
• Miao S, Shi M, Zou L, Wang G. Effect of intrathecal dexmedetomidine on preventing shivering in cesarean section after spinal anesthesia: a meta-analysis and trial sequential analysis. Drug Des Devel Ther. 2018;12:3775–3783. doi:10.2147/DDDT.S178665
   PubMed Web of Science ®Google Scholar
• Wang Y-Q, Zhang X-J, Wang Y. Effect of intrathecal dexmedetomidine on cesarean section during spinal anesthesia: a meta-analysis of randomized trials. Drug Des Devel Ther. 2019;13:2933–2939. doi:10.2147/DDDT.S207812
   PubMed Web of Science ®Google Scholar
• Lamontagne C, Lesage S, Villeneuve E, Lidzborski E, Derstenfeld A, Crochetière C. Intravenous dexmedetomidine for the treatment of shivering during cesarean delivery under neuraxial anesthesia: a randomized-controlled trial. Can J Anaesth. 2019;66(7):762–771. doi:10.1007/s12630-019-01354-3
   PubMed Web of Science ®Google Scholar
• Ao L, Shi J, Bai Y, Zheng Y, Gan J. Effectiveness and safety of intravenous application of dexmedetomidine for cesarean section under general anesthesia: a meta-analysis of randomized trials. Drug Des Devel Ther. 2019;13:965–974. doi:10.2147/DDDT.S197165
   PubMed Web of Science ®Google Scholar
• Tobias JD. Dexmedetomidine and ketamine. Pediatr Crit Care Med. 2012;13(4):423–427. doi:10.1097/PCC.0b013e318238b81c
   PubMed Web of Science ®Google Scholar
• Hirabayashi Y, Saitoh K, Fukuda H, Shimizu R. Visceral pain during caesarean section: effect of varying dose of spinal amethocaine. Br J Anaesth. 1995;75(3):266–268. doi:10.1093/bja/75.3.266
   PubMed Web of Science ®Google Scholar
• Cervero F. Mechanisms of acute visceral pain. Br Med Bull. 1991;47(3):549–560. doi:10.1093/oxfordjournals.bmb.a072492
   PubMed Web of Science ®Google Scholar
• Liu S, Peng P, Hu Y, et al. The effectiveness and safety of intravenous dexmedetomidine of different concentrations combined with butorphanol for post-caesarean section analgesia: a randomized controlled trial. Drug Des Devel Ther. 2021;15:689–698. doi:10.2147/DDDT.S287512
   PubMed Web of Science ®Google Scholar
• Liu Q-R, Zong Q-K, Ding -L-L, et al. Effects of perioperative use of esketamine on postpartum depression risk in patients undergoing cesarean section: a randomized controlled trial. J Affective Disorders. 2023;339:815–822. doi:10.1016/j.jad.2023.07.103
   PubMed Web of Science ®Google Scholar
• H-Y Y, Wang S-Y, Quan C-X, et al. Dexmedetomidine alleviates postpartum depressive symptoms following cesarean section in Chinese women: a randomized placebo-controlled study. Pharmacotherapy. 2019;39(10):994–1004. doi:10.1002/phar.2320
   PubMed Web of Science ®Google Scholar
• Musk GC, Netto JD, Maker GL, Trengove RD. Transplacental transfer of medetomidine and ketamine in pregnant ewes. Lab Anim. 2012;46(1):46–50. doi:10.1258/la.2011.010179
   PubMedGoogle Scholar
• Ellingson A, Haram K, Sagen N, Solheim E. Transplacental passage of ketamine after intravenous administration. Acta Anaesthesiol Scand. 1977;21(1):41–44. doi:10.1111/j.1399-6576.1977.tb01191.x
   PubMed Web of Science ®Google Scholar
• Cheung HM, Yew DTW. Effects of perinatal exposure to ketamine on the developing brain. Front Neurosci. 2019;13:138. doi:10.3389/fnins.2019.00138
   PubMed Web of Science ®Google Scholar
• Brambrink AM, Evers AS, Avidan MS, et al. Ketamine-induced neuroapoptosis in the fetal and neonatal rhesus macaque brain. Anesthesiology. 2012;116(2):372–384. doi:10.1097/ALN.0b013e318242b2cd
   PubMed Web of Science ®Google Scholar
• Sen S, Ozmert G, Aydin ON, Baran N, Caliskan E. The persisting analgesic effect of low-dose intravenous ketamine after spinal anaesthesia for caesarean section. Eur J Anaesthesiol. 2005;22(7):518–523. doi:10.1017/S026502150500089X
   PubMed Web of Science ®Google Scholar
• Gong R-S, Liu X-W, W-X L, Zhao J. Effects of colloid preload on the incidence of hypotension in spinal anesthesia for cesarean section: a systematic review and meta-analysis. Chinese Med J. 2021;134(9):1043–1051. doi:10.1097/cm9.0000000000001477
   PubMed Web of Science ®Google Scholar
• Kienbaum P, Heuter T, Pavlakovic G, Michel MC, Peters J. S(+)-ketamine increases muscle sympathetic activity and maintains the neural response to hypotensive challenges in humans. Anesthesiology. 2001;94(2):252–258. doi:10.1097/00000542-200102000-00014
   PubMed Web of Science ®Google Scholar
• Liu J, Wang Y, Ma W. Shivering prevention and treatment during cesarean delivery under neuraxial anesthesia: a systematic review. Minerva Anestes. 2018;84(12). doi:10.23736/s0375-9393.18.12478-3
   Web of Science ®Google Scholar
• Gastaldon C, Raschi E, Kane John M, Barbui C, Schoretsanitis G. Post-marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system. Psychothe Psycho. 2021;90(1):41–48. doi:10.1159/000510703
   PubMed Web of Science ®Google Scholar
• Feeney A, Papakostas GI. Pharmacotherapy. Psychiat Clin North Am. 2023;46(2):277–290. doi:10.1016/j.psc.2023.02.003
   PubMed Web of Science ®Google Scholar